Abstract Submissions & Guidelines
Deadline for Regular Submission:
November 4, 2024.
* Late Breaking Abstract Submission Deadline:
November 11 - 25th, 2024
We are pleased to inform you that accepted abstracts, submitted by registered participants, will have the privilege of being published in the esteemed journal Metabolism, providing a valuable platform for sharing your research findings with the scientific community. Your work will reach a broad audience, making a significant impact in the field and fostering collaborations for future research.
Accepted abstracts will have the opportunity to present their work in the Abstract Hall, facilitating fruitful discussions and knowledge exchange during the event. Following this, our abstract committee will select the top 6 abstracts for the Abstract Oral Presentation Session during the conference, offering researchers an additional platform to showcase their groundbreaking work. In special cases, we may consider Late Breaking Abstracts for the oral presentation session. However, we strongly recommend early submission as it increases your chances of securing a spot among the top selections. Late Breaking submissions will fill only 2 out of 6 slots, whereas submitting early provides a chance for you to secure one of the first 4 slots.
To recognize excellence in research, the top abstracts will receive prestigious awards and cash prizes at the Gold, Silver, Bronze, and Honorable Mention levels, motivating scholars to continue contributing to the advancement of knowledge in this field.
For any inquiries or further information, please do not hesitate to contact us at firstname.lastname@example.org. We are here to assist and support you in making your participation at the event a rewarding experience. Thank you for your dedication to scientific advancement, and we look forward to your active involvement at the conference.
View a sample abstract submission from the PDF below:
Abstract Submission & Topics:
Clinical Aspects of Insulin Resistance Across Lifespan: Explore insulin resistance's clinical dimensions in childhood, adolescence, and adulthood, encompassing domains such as diabetes, obesity, dyslipidemia, hypertension, cardiovascular disease, malignancy, liver disease, renal dysfunction, gonadal anomalies, and sleep disorders including obstructive sleep apnea.
Investigate mechanisms underlying insulin resistance, inflammation, endothelial and vascular anomalies, and metabolic dysfunction in pivotal centers like the beta cell, adipocyte, gut, and brain.
Submitted abstracts should focus on clinical or basic science aspects of insulin resistance, extending to areas like diabetes, obesity, and cardiovascular disease. Investigating overall pathophysiology and effects on key metabolic centers (e.g., beta cell, adipocyte, gut, brain), as well as studies related to inflammation and endothelial or vascular anomalies, are of interest. Clinical topics can span insulin resistance's role in conditions such as obesity, diabetes, hypertension, dyslipidemia, cardiovascular disease, renal dysfunction, gonadal irregularities (including PCOS and male hypogonadism), gestational diabetes, other endocrine disorders, liver disease (NAFLD), malignancy, and sleep disorders like obstructive sleep apnea.
WCIRDC is also keen on exploring multi-hormonal aspects of obesity, gut hormonal contributions (including incretins) to energy balance, and the influence of circadian rhythms on metabolic mechanisms. Basic science studies should feature a specific link to insulin action and its regulation at the cellular, organ, or whole-body levels. To align with these guidelines, authors are encouraged to provide a brief explanation of how their topic relates to insulin resistance and/or the aforementioned metabolic processes.
Abstract Poster Presentations:
Abstracts can be submitted for poster presentations. If selected for poster presentation, the author or presenter must register for the conference and attend the poster sessions. The presenter MUST be one of the listed authors in the abstract.
Abstract Oral Presentations
Our Abstract Committee will select the top 6 abstracts for the Abstract Oral Presentation Session during the conference, offering researchers an additional platform to showcase their groundbreaking work. In some cases, the committee may consider Late-Breaking Abstracts for oral presentation. However, we strongly recommend early submission as it increases your chances of securing a spot among the top selections. Late Breaking submissions will fill only 2 out of 6 slots, whereas submitting early provides a chance for you to secure one of the first 4 slots.
The authors of the winning abstracts will present their research findings in a 10-minute presentation, followed by 5 minutes of Q&A. If selected, an author is required to register for the meeting and to be prepared with a PowerPoint presentation. Oral presenters who have an interest or involvement in selling a technology, program, product, and/or service to healthcare professionals must submit an official disclosure document to be considered for and to present their work at the abstract oral session.
Top Abstract Awards
Awards will be presented to the highest-ranking abstracts, categorized as Gold, Silver, Bronze, and Honorable Mentions. These designations are determined from the pool of Abstract Oral Presentation Winners. The top 3 winners of the Abstract Oral Presentation will be granted a fast-track opportunity by the Metabolism Journal if they submit their full papers within 60 days following their oral abstract presentation at the conference. The submitted paper will undergo peer review, and its acceptance is not guaranteed.
The Metabolism: Clinical and Experimental Journal (Impact Factor 13.94), under the editorial guidance of Dr. Christos Mantzoros, MD, PhD, serves as the platform for this scholarly endeavor.
Abstracts and scientific material presented at the conference must not have been published or presented prior to December 12, 2024.
Encore abstracts are accepted under special circumstances, provided that upon selection at least one of the authors should be registered for the conference and is present on-site to present their posters during the meeting. Please note that Encore abstracts will not be published under Metabolism and will not be eligible for oral abstract presentations or awards.
All abstracts must be submitted electronically on a Microsoft Word document of no more than 250 words. Please do not submit any graphs, tables, figures, or references (No PDF documents will be accepted, or any submissions by fax or mail). For sample formatting, please click here.
All materials must arrive on or before the abstract deadline noted above.
Notification for acceptance will be e-mailed as soon as the committee accepts the abstract.
Authorship on multiple abstracts is permitted.
All submitted materials will be graded by the scientific planning committee, The International Committee for Insulin Resistance.
If an author wishes to make changes or to withdraw their abstract, they must contact the WCIRDC team no later than November 25 2024. WCIRDC cannot guarantee that any change or withdrawal requests submitted after this date will be accommodated. All requests should be submitted via email to email@example.com